Lista de obras - Tjoung-Won Park-Simon - Dominio Público Uruguay

A role for XRCC2 gene polymorphisms in breast cancer risk and survival

artículo científico publicado en 2011

A tumor-derived population (SCCOHT-1) as cellular model for a small cell ovarian carcinoma of the hypercalcemic type

artículo científico publicado en 2012

Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study

artículo científico

Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study

artículo científico publicado en 2018

Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers

artículo científico publicado en 2016

Analysis of a RECQL splicing mutation, c.1667_1667+3delAGTA, in breast cancer patients and controls from Central Europe

artículo científico publicado en 2016

Assessment of a FBXW8 frameshift mutation, c.1312_1313delGT, in breast cancer patients and controls from Central Europe

artículo científico publicado en 2017

Assessment of an APOBEC3B truncating mutation, c.783delG, in patients with breast cancer

artículo científico publicado en 2017

Association analysis identifies 65 new breast cancer risk loci.

artículo científico publicado en 2017

Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies

artículo científico publicado en 2010

CYP2B6*6 is associated with increased breast cancer risk

artículo científico publicado en 2013

Clinical outcome of brain metastases differs significantly among breast cancer subtypes

artículo científico publicado en 2017

Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes

article

Functional deficiency of NBN, the Nijmegen breakage syndrome protein, in a p.R215W mutant breast cancer cell line

artículo científico publicado en 2014

Genetic modifiers of CHEK2*1100delC-associated breast cancer risk

scientific article published on 06 October 2016

Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

article

Germline variation in TP53 regulatory network genes associates with breast cancer survival and treatment outcome

artículo científico publicado en 2012

Guideline adherence and clinical outcome in vulnerable and healthy breast cancer patients: Results of a prospective cross-sectional study in Germany

article

Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

artículo científico publicado en 2016

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

artículo científico publicado en 2017

In vitro and in vivo therapeutic approach for a small cell carcinoma of the ovary hypercalcaemic type using a SCCOHT-1 cellular model

artículo científico publicado en 2014

Incorporating progesterone receptor expression into the PREDICT breast prognostic model

artículo científico publicado en 2022

LEF-1 regulates proliferation and MMP-7 transcription in breast cancer cells

artículo científico publicado en 2012

Mutation analysis of BRCA1, BRCA2, PALB2 and BRD7 in a hospital-based series of German patients with triple-negative breast cancer

artículo científico publicado en 2012

Mutation analysis of the ERCC4/FANCQ gene in hereditary breast cancer

artículo científico publicado en 2014

Mutation analysis of the SLX4/FANCP gene in hereditary breast cancer

artículo científico publicado en 2011

Nonsense mutation p.Q548X in BLM, the gene mutated in Bloom's syndrome, is associated with breast cancer in Slavic populations

artículo científico publicado en 2012

Phase III study on efficacy of taxanes plus bevacizumab with or without capecitabine as first-line chemotherapy in metastatic breast cancer

artículo científico publicado en 2014

Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

artículo científico publicado en 2019

Prediction of breast cancer risk based on profiling with common genetic variants

artículo científico publicado en 2015

Prevalence of PALB2 mutation c.509_510delGA in unselected breast cancer patients from Central and Eastern Europe

artículo científico publicado en 2014

Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1).

artículo científico publicado en 2017

Prevalence of the BLM nonsense mutation, p.Q548X, in ovarian cancer patients from Central and Eastern Europe

artículo científico publicado en 2015

Radiological Patterns of Brain Metastases in Breast Cancer Patients: A Subproject of the German Brain Metastases in Breast Cancer (BMBC) Registry

artículo científico publicado en 2016

Rare ATAD5 missense variants in breast and ovarian cancer patients

artículo científico publicado en 2016

Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

artículo científico publicado en 2014

Role of p16 and p14ARF in radio- and chemosensitivity of malignant gliomas

artículo científico publicado en 2006

Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial ⬇️

artículo científico publicado en 2015

Temsirolimus in women with platinum-refractory/resistant ovarian cancer or advanced/recurrent endometrial carcinoma. A phase II study of the AGO-study group (AGO-GYN8).

artículo científico publicado en 2015

The Benefit of Baseline Staging-Risk Assessment of Distant Breast Cancer Metastases by Tumor Stage

artículo científico publicado en 2016

The First Description of Docetaxel-Induced Recall Inflammatory Skin Reaction after Previous Drug Extravasation ⬇️

artículo científico publicado el 1 de febrero de 2011

The role of genetic breast cancer susceptibility variants as prognostic factors

artículo científico publicado en 2012

Lista de obras de Tjoung-Won Park-Simon

A role for XRCC2 gene polymorphisms in breast cancer risk and survival

A tumor-derived population (SCCOHT-1) as cellular model for a small cell ovarian carcinoma of the hypercalcemic type

Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study

Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study

Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers

Analysis of a RECQL splicing mutation, c.1667_1667+3delAGTA, in breast cancer patients and controls from Central Europe

Assessment of a FBXW8 frameshift mutation, c.1312_1313delGT, in breast cancer patients and controls from Central Europe

Assessment of an APOBEC3B truncating mutation, c.783delG, in patients with breast cancer

Association analysis identifies 65 new breast cancer risk loci.

Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies

CYP2B6*6 is associated with increased breast cancer risk

Clinical outcome of brain metastases differs significantly among breast cancer subtypes

Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes

Functional deficiency of NBN, the Nijmegen breakage syndrome protein, in a p.R215W mutant breast cancer cell line

Genetic modifiers of CHEK2*1100delC-associated breast cancer risk

Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

Germline variation in TP53 regulatory network genes associates with breast cancer survival and treatment outcome

Guideline adherence and clinical outcome in vulnerable and healthy breast cancer patients: Results of a prospective cross-sectional study in Germany

Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

In vitro and in vivo therapeutic approach for a small cell carcinoma of the ovary hypercalcaemic type using a SCCOHT-1 cellular model

Incorporating progesterone receptor expression into the PREDICT breast prognostic model

LEF-1 regulates proliferation and MMP-7 transcription in breast cancer cells

Mutation analysis of BRCA1, BRCA2, PALB2 and BRD7 in a hospital-based series of German patients with triple-negative breast cancer

Mutation analysis of the ERCC4/FANCQ gene in hereditary breast cancer

Mutation analysis of the SLX4/FANCP gene in hereditary breast cancer

Nonsense mutation p.Q548X in BLM, the gene mutated in Bloom's syndrome, is associated with breast cancer in Slavic populations

Phase III study on efficacy of taxanes plus bevacizumab with or without capecitabine as first-line chemotherapy in metastatic breast cancer

Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

Prediction of breast cancer risk based on profiling with common genetic variants

Prevalence of PALB2 mutation c.509_510delGA in unselected breast cancer patients from Central and Eastern Europe

Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1).

Prevalence of the BLM nonsense mutation, p.Q548X, in ovarian cancer patients from Central and Eastern Europe

Radiological Patterns of Brain Metastases in Breast Cancer Patients: A Subproject of the German Brain Metastases in Breast Cancer (BMBC) Registry

Rare ATAD5 missense variants in breast and ovarian cancer patients

Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

Role of p16 and p14ARF in radio- and chemosensitivity of malignant gliomas

Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial ⬇️

Temsirolimus in women with platinum-refractory/resistant ovarian cancer or advanced/recurrent endometrial carcinoma. A phase II study of the AGO-study group (AGO-GYN8).

The Benefit of Baseline Staging-Risk Assessment of Distant Breast Cancer Metastases by Tumor Stage

The First Description of Docetaxel-Induced Recall Inflammatory Skin Reaction after Previous Drug Extravasation ⬇️

The role of genetic breast cancer susceptibility variants as prognostic factors